MEAC
BMY icon

M.E. Allison & Co’s Bristol-Myers Squibb BMY Stock Holding History

M.E. Allison & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$479K Sell
8,318
-498
-6% -$28.6K 0.28% 97
2026
Q1 		$535K Buy
8,816
+2
+0% +$117 0.35% 76
2025
Q4 		$475K Buy
8,814
+1
+0% +$48 0.32% 85
2025
Q3 		$397K Buy
8,813
+52
+0.6% +$2.43K 0.28% 94
2025
Q2 		$406K Buy
8,761
+1,348
+18% +$66.2K 0.33% 81
2025
Q1 		$452K Buy
7,413
+3
+0% +$175 0.45% 66
2024
Q4 		$419K Buy
+7,410
New +$414K 0.46% 65

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

M.E. Allison & Co's BMY Position: Q2 2026 in Review

M.E. Allison & Co reduced its Bristol-Myers Squibb (BMY) stake by 5.6% in Q2 2026, selling an estimated $28.6K and leaving 8,318 shares worth $479K. The position accounts for 0.28% of the portfolio, ranked #97.

M.E. Allison & Co first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $535K in Q1 2026. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • M.E. Allison & Co held 8,318 shares of Bristol-Myers Squibb worth $479K as of Q2 2026.
  • M.E. Allison & Co sold 498 Bristol-Myers Squibb shares in Q2 2026, an estimated $28.6K.
  • Bristol-Myers Squibb made up 0.28% of M.E. Allison & Co's portfolio in Q2 2026, its #97 holding.
  • M.E. Allison & Co first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • M.E. Allison & Co's Bristol-Myers Squibb position peaked at $535K in Q1 2026.
  • 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on M.E. Allison & Co's 13F filing for Q2 2026, filed 7 Jul 2026.